News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Santarus Inc. Reports First Quarter 2011 Financial Results
May 5, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, today reported financial and operating results for the quarter ended March 31, 2011. Key financial results for the 2011 first quarter include:
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Podcast
Q2 earnings underway, FDA’s CRL kerfuffle, IPOs full speed ahead in H2
July 22, 2026
·
1 min read
·
Jef Akst
Manufacturing
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
July 21, 2026
·
2 min read
·
Nick Paul Taylor
Sickle cell disease
Agios axes next-gen sickle cell candidate after it fails to best Novo’s asset
July 21, 2026
·
2 min read
·
Gabrielle Masson
Earnings
Novartis stays ‘geography-agnostic’ in dealmaking amid flurry of China deals
July 21, 2026
·
2 min read
·
Tristan Manalac
